Our data suggest that JNK‐IN‐8 treatment improves ARDS‐induced cognitive impairment by inhibiting the JNK/NF‐?B‐mediated NLRP3 inflammasome. The gene discussed is MAPK8; the disease is acute respiratory distress syndrome.